Study the effect some of antioxidant in polycystic ovary syndrome women

Zahraa Sabah Abd; Sundus Kareem Hamzah

doi:10.53730/ijhs.v6nS4.11387

Authors

Zahraa Sabah Abd
zahraasabah2022@gmail.com
Chemistry dept. Education college / AL-Qadissiya University/ Iraq
Sundus Kareem Hamzah Chemistry dept. Education college / AL-Qadissiya University/ Iraq

Keywords:

antioxidant, oxidative marker, oxidative stress, polycystic ovary syndrome, reactive oxygen species

Abstract

This study was conducted at the Women and Children’s Hospital in Al-Qadisiyah from 1/10/2021 to 2/1/2022, and 50 patients were followed up for women suffering from polycystic ovaries on the third day of the menstrual cycle, and compared to the control group, which included 50 normal cases, which were confirmed to be free. Of the chronic diseases such as heart disease, thyroid, diabetes and blood pressure, the concentration of antioxidants was measured for both infected and non-infected women, including SOD, UA and MDA. A significant increase in antioxidants and decrease GSH was observed in women with PCOS compared to the control group. The concentration of copper, zinc, Cu and Zn elements was also measured, as we showed a high concentration of copper and a decrease in zinc in women with polycystic ovary syndrome compared to the control group.

Downloads

Download data is not yet available.

References

Abedini, M., Ghaedi, E., Hadi, A., Mohammadi, H. & Amani, R. Zinc status and polycystic ovarian syndrome: A systematic review and meta-analysis. J. Trace Elem. Med. Biol. 52, 216–221 (2019).

Abuja, P. M. & Albertini, R. Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. Clin. Chim. acta 306, 1–17 (2001).

Agarwal, A., Gupta, S. & Sharma, R. K. Role of oxidative stress in female reproduction. Reprod. Biol. Endocrinol. 3, 1–21 (2005).

Agarwal, A., Gupta, S., Sekhon, L. & Shah, R. Redox considerations in female reproductive function and assisted reproduction: from molecular mechanisms to health implications. Antioxid. Redox Signal. 10, 1375–1404 (2008).

Beletate, V., El Dib, R. & Atallah, Á. N. Zinc supplementation for the prevention of type 2 diabetes mellitus. Cochrane Database Syst. Rev. (2007).

Celik, C. et al. The relationship between copper, homocysteine and early vascular disease in lean women with polycystic ovary syndrome. Gynecol. Endocrinol. 29, 488–491 (2013).

Chakraborty, P. et al. Altered trace mineral milieu might play an aetiological role in the pathogenesis of polycystic ovary syndrome. Biol. Trace Elem. Res. 152, 9–15 (2013).

Chang, J. et al. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004). Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81, 19–25 (2004).

Chéreau, D. A. Mémoires pour servir à l’étude des maladies des ovaires. Premier mémoire contenant: 1° les considérations anatomiques et physiologiques; 2° l’agénésie et les vices de conformation des ovaires; 3° l’inflammation aiguë des ovaires, ovarite aiguë, par Achill. (Fortin, Masson, 1844).

Coviello, A. D., Legro, R. S. & Dunaif, A. Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. J. Clin. Endocrinol. Metab. 91, 492–497 (2006).

Davey, M. W., Stals, E., Panis, B., Keulemans, J. & Swennen, R. L. High-throughput determination of malondialdehyde in plant tissues. Anal. Biochem. 347, 201–207 (2005).

Deba, Z., Jambale, T. A., Swamy, P. M. G. & Murthy, D. S. J. Study of levels of malondialdehyde, super oxide dismutase and hs-CRP in serum of non-obese patients with polycystic ovarian syndrome. Int J Clin Biochem 4, 191–194 (2017).

Deepika, M. L. et al. Analysis of oxidative stress status through MN test and serum MDA levels in PCOS women. Pak. J. Biol. Sci. 17, 574–577 (2014).

Dewailly, D. et al. Interactions between androgens, FSH, anti-mullerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary. Médecine la Reprod. 21, 145–163 (2019).

Diyu, I. A. N. P., & Satriani, N. L. A. (2022). Menopausal symptoms in women aged 40-65 years in Indonesia. International Journal of Health & Medical Sciences, 5(2), 169-176. https://doi.org/10.21744/ijhms.v5n2.1896

Dosa, M. D., Adumitresi, C. R., Hangan, L. T. & Nechifor, M. Copper, zinc and magnesium in non-insulin-dependent diabetes mellitus treated with metformin. Diabetes Mellitus-Insights Perspect. (2013).

Dumont, A., Robin, G. & Dewailly, D. Anti-müllerian hormone in the pathophysiology and diagnosis of polycystic ovarian syndrome. Curr. Opin. Endocrinol. Diabetes Obes. 25, 377–384 (2018).

Dursun, P., Demirtaş, E., Bayrak, A. & Yarali, H. Decreased serum paraoxonase 1 (PON1) activity: an additional risk factor for atherosclerotic heart disease in patients with PCOS? Hum. Reprod. 21, 104–108 (2006).

Federico, A., Morgillo, F., Tuccillo, C., Ciardiello, F. & Loguercio, C. Chronic inflammation and oxidative stress in human carcinogenesis. Int. J. cancer 121, 2381–2386 (2007).

Joham, A. E., Teede, H. J., Ranasinha, S., Zoungas, S. & Boyle, J. Prevalence of infertility and use of fertility treatment in women with polycystic ovary syndrome: data from a large community-based cohort study. J. women’s Heal. 24, 299–307 (2015).

Klotz, L.-O., Kröncke, K.-D., Buchczyk, D. P. & Sies, H. Role of copper, zinc, selenium and tellurium in the cellular defense against oxidative and nitrosative stress. J. Nutr. 133, 1448S-1451S (2003).

Kurdoglu, Z., Kurdoglu, M., Demir, H. & Sahin, H. G. Serum trace elements and heavy metals in polycystic ovary syndrome. Hum. Exp. Toxicol. 31, 452–456 (2012).

Kuşçu, N. K. & Var, A. Oxidative stress but not endothelial dysfunction exists in non-obese, young group of patients with polycystic ovary syndrome. Acta Obstet. Gynecol. Scand. 88, 612–617 (2009).

Li, M. et al. Serum macroelement and microelement concentrations in patients with polycystic ovary syndrome: a cross-sectional study. Biol. Trace Elem. Res. 176, 73–80 (2017).

Liochev, S. I. Reactive oxygen species and the free radical theory of aging. Free Radic. Biol. Med. 60, 1–4 (2013).

Mu, L. et al. Association between the prevalence of hyperuricemia and reproductive hormones in polycystic ovary syndrome. Reprod. Biol. Endocrinol. 16, 1–6 (2018).

Murri, M., Luque-Ramírez, M., Insenser, M., Ojeda-Ojeda, M. & Escobar-Morreale, H. F. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum. Reprod. Update 19, 268–288 (2013).

Nasiri, N. et al. Abdominal obesity can induce both systemic and follicular fluid oxidative stress independent from polycystic ovary syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 184, 112–116 (2015).

Norman, R. J., Dewailly, D., Legro, R. S. & Hickey, T. E. Polycystic ovary syndrome. Lancet 370, 685–697 (2007).

Palacio, J. R., Iborra, A., Ulcova-Gallova, Z., Badia, R. & Martinez, P. The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patients. Clin. Exp. Immunol. 144, 217–222 (2006).

Paszkowski, T., Traub, A. I., Robinson, S. Y. & McMaster, D. Selenium dependent glutathione peroxidase activity in human follicular fluid. Clin. Chim. Acta 236, 173–180 (1995).

Perry, J. J. P., Shin, D. S., Getzoff, E. D. & Tainer, J. A. The structural biochemistry of the superoxide dismutases. Biochim. Biophys. Acta (BBA)-Proteins Proteomics 1804, 245–262 (2010).

POURTEYMOURFARD, T. F., ALIPOUR, B. A., MEHRZAD, S. M. & OSTAD, R. A. R. Effect of zinc supplementation on cardiometabolic risk factors in women with polycystic ovary syndrome. (2010).

Rad, S. S. et al. Evaluation of the melatonin and oxidative stress markers level in serum of fertile and infertile women. Iran. J. Reprod. Med. 13, 439 (2015).

Sabuncu, T., Vural, H., Harma, M. & Harma, M. Oxidative stress in polycystic ovary syndrome and its contribution to the risk of cardiovascular disease☆. Clin. Biochem. 34, 407–413 (2001).

Shorakae, S. et al. Inter‐related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS. Clin. Endocrinol. (Oxf). 89, 628–633 (2018).

Sohrabvand, F., Shirazi, M., Shariat, M., & Mahdiyin, F. (2013). Serum zinc level in infertile women with and without polycystic ovary syndrome: a comparative study. Tehran University Medical Journal, 71(3).Sohrabvand, F., Shirazi, M., Shariat, M. & Mahdiyin, F. Serum zinc level in infertile women with and without polycystic ovary syndrome: a comparative study. Tehran Univ. Med. J. 71, (2013).

Sumithra, N. U. C., Lakshmi, R. L., Leela Menon, N., Subhakumari, K. N. & Sheejamol, V. S. Evaluation of oxidative stress and hsCRP in polycystic ovarian syndrome in a tertiary care hospital. Indian J. Clin. Biochem. 30, 161–166 (2015).

Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Get vaccinated when it is your turn and follow the local guidelines. International Journal of Health Sciences, 5(3), x-xv. https://doi.org/10.53730/ijhs.v5n3.2938

Teede, H. J. et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum. Reprod. 33, 1602–1618 (2018).

Wild, R. A. et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J. Clin. Endocrinol. Metab. 95, 2038–2049 (2010).

Yu, S. et al. Prevalence of hyperuricemia and its correlates in rural Northeast Chinese population: from lifestyle risk factors to metabolic comorbidities. Clin. Rheumatol. 35, 1207–1215 (2016).

Zhang, D., Luo, W.-Y., Liao, H., Wang, C.-F. & Sun, Y. The effects of oxidative stress to PCOS. Sichuan da xue xue bao. Yi xue ban= J. Sichuan Univ. Med. Sci. Ed. 39, 421–423 (2008).

Zheng, Y.-H. et al. Effect of low-frequency electroacupuncture intervention on oxidative stress and glucose metabolism in rats with polycystic ovary syndrome. Zhen ci yan jiu= Acupunct. Res. 40, 125–130 (2015).